Literature DB >> 7956458

Anticarcinogenic effect of Commiphora molmol on solid tumors induced by Ehrlich carcinoma cells in mice.

M M al-Harbi1, S Qureshi, M Raza, M M Ahmed, A B Giangreco, A H Shah.   

Abstract

The anticarcinogenic potential of Commiphora molmol (oleoresin) was studied in Ehrlich-solid-tumor-bearing mice. The antitumor activity of C. molmol was evaluated from the total count and viability of Ehrlich solid tumor cells and their nucleic acid, protein, malondialdehyde and glutathione levels at the end of 25 and 50 days of treatment. Furthermore, observations of animal survival rate and measurements of the tumor and body weight were made. The Ehrlich solid tumors were also evaluated for histopathological changes. Treatment with C. molmol (250 and 500 mg/kg/day) was found to be cytotoxic in Ehrlich solid tumors cells. The antitumor potential of C. molmol was comparable to the standard cytotoxic drug cyclophosphamide. This effect of C. molmol was less pronounced after 50 days of treatment. The present study confirmed the cytotoxic and anticarcinogenic potential of C. molmol. Further studies are warranted to explore its mode of action and safety for medicinal use in cancer therapy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7956458     DOI: 10.1159/000239216

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  3 in total

Review 1.  Herbs in dentistry.

Authors:  Jamile B Taheri; Somayyeh Azimi; Nasrin Rafieian; Hosein Akhavan Zanjani
Journal:  Int Dent J       Date:  2011-11-03       Impact factor: 2.607

Review 2.  Conventional and alternative treatment approaches for Clostridium difficile infection.

Authors:  Khalid M Aljarallah
Journal:  Int J Health Sci (Qassim)       Date:  2017 Jan-Mar

3.  Efficacy of Commiphora myrrh mouthwash on early wound healing after tooth extraction: A randomized controlled trial.

Authors:  Raniah Abdullah Al Eid
Journal:  Saudi Dent J       Date:  2019-12-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.